T. Rowe Price Associates’s Xperi XPER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$657K Buy
79,721
+15,087
+23% +$109K ﹤0.01% 2494
2026
Q1
$362K Buy
64,634
+8,564
+15% +$49.6K ﹤0.01% 2586
2025
Q4
$329K Sell
56,070
-7,485
-12% -$46.9K ﹤0.01% 2608
2025
Q3
$412K Buy
63,555
+3,108
+5% +$20.5K ﹤0.01% 2447
2025
Q2
$479K Buy
60,447
+663
+1% +$5K ﹤0.01% 2324
2025
Q1
$462K Buy
59,784
+1,783
+3% +$15.6K ﹤0.01% 2278
2024
Q4
$596K Sell
58,001
-8,608
-13% -$80.4K ﹤0.01% 2214
2024
Q3
$616K Sell
66,609
-2,557
-4% -$21K ﹤0.01% 2172
2024
Q2
$568K Buy
69,166
+6,318
+10% +$59.7K ﹤0.01% 2144
2024
Q1
$758K Buy
62,848
+2,030
+3% +$22.3K ﹤0.01% 2033
2023
Q4
$671K Buy
60,818
+10,037
+20% +$96.8K ﹤0.01% 2050
2023
Q3
$501K Buy
50,781
+3,315
+7% +$39.2K ﹤0.01% 2106
2023
Q2
$625K Buy
47,466
+3,523
+8% +$38.2K ﹤0.01% 2031
2023
Q1
$481K Buy
43,943
+7,528
+21% +$78.5K ﹤0.01% 2125
2022
Q4
$314K Buy
+36,415
New +$417K ﹤0.01% 2359

Other funds holding XPER

T. Rowe Price Associates's XPER Position: Q2 2026 in Review

T. Rowe Price Associates increased its Xperi (XPER) stake by 23% in Q2 2026, buying an estimated $109K and bringing the position to 79,721 shares worth $657K. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

T. Rowe Price Associates first reported a position in XPER in Q4 2022 and has held it in 15 quarters since. The position peaked at $758K in Q1 2024. 154 funds tracked by Wall St. Rank hold XPER as of Q2 2026.

  • T. Rowe Price Associates held 79,721 shares of Xperi worth $657K as of Q2 2026.
  • T. Rowe Price Associates bought 15,087 Xperi shares in Q2 2026, an estimated $109K.
  • Xperi made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2494 holding.
  • T. Rowe Price Associates first reported a position in Xperi in Q4 2022 and has held it in 15 quarters since.
  • T. Rowe Price Associates's Xperi position peaked at $758K in Q1 2024.
  • 154 funds tracked by Wall St. Rank held Xperi as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.